Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7356776

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
48,824,000,000 JPY
60,461,000,000 JPY
47,259,000,000 JPY
Ordinary profit (loss)
5,631,000,000 JPY
5,232,000,000 JPY
5,246,000,000 JPY
Net assets
60,391,000,000 JPY
54,533,000,000 JPY
54,080,000,000 JPY
Total assets
94,857,000,000 JPY
87,138,000,000 JPY
90,794,000,000 JPY
Basic earnings (loss) per share
228.13
82.19
150.08
148.19
64.97
Diluted earnings per share
Equity-to-asset ratio
0.637 xbrli:pure
0.626 xbrli:pure
0.596 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.